The European Medicines Agency (EMA) has recommended the approval of Moderna's LP.8.1-adapted COVID-19 vaccine to address the challenges posed by the SARS-CoV-2 variant LP.8.1. Following the guidance of EMA's Emergency Task Force, the formulation of Spikevax has been tailored to combat the current
Healthcare in prison settings has become a focal point of concern, with an emphasis on the technological disconnect undermining patient safety and efficiency. This issue is underscored by findings from various health oversight bodies, indicating a critical lack of interoperability between prison
Is the future of cancer therapy already taking shape in laboratories today? With each advance in medical science, there comes hope for more effective treatments against malignant diseases. Immunotherapy, a rapidly evolving approach, has been positioned as a groundbreaking method in combating cancer
In a bold maneuver to realign its strategic focus, Belgian pharmaceutical firm Galapagos is contemplating the sale of its cell therapy unit, a move that represents a significant departure from its initial restructuring plan. Originally, this unit was poised to become the cornerstone of a strategic
In the ever-evolving world of biopharma and medical research, experts like Ivan Kairatov are at the frontier of innovation. With profound expertise in technology and development within the sector, Ivan sheds light on a groundbreaking development that could redefine how we understand aging. The
In the ever-evolving landscape of biotechnology and pharmaceuticals, Ivan Kairatov stands as a respected authority, particularly in tech and innovation within the biopharma sector. He joins us today to discuss recent developments concerning a compound known as inidascamine. Originally developed by
Recent strides in nanotechnology have opened up new possibilities in sustainable biofuel production, specifically from microalgae. This cutting-edge approach offers transformative potential that could reshape energy industries by improving the yield and efficiency of biofuel from algae, a promising
With multiple myeloma cases surpassing 50,000 annually across Europe, the quest for a more effective treatment has never been more urgent. Despite its classification as a rare cancer, its profound impact on affected individuals and healthcare systems is undeniable. Imagine a treatment that could
Glioblastoma is an aggressive form of brain cancer with a median survival rate of just nine months post-diagnosis. This grim statistic raises important questions about the effectiveness of current treatments and the desperate need for new approaches. Consider the journey of many patients, whose
In recent discussions surrounding healthcare technology, Doximity emerges as a key player, leveraging AI-driven tools and telehealth services crafted mainly for physicians. As the industry landscape changes, the company garners attention not just for its innovative products but also for its
